Rocket Pharmaceuticals secures $150M credit facility
- $35M funded on Sept 30, 2026
- Up to $150M in tranches with milestone-based draws
- Warrants to purchase 1.76M shares issued
Every EDGAR filing for ROCKET PHARMACEUTICALS, INC. (RCKTW), newest first, with AI summaries and stories.
Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.
Martin Wilson, insider filing for RCKTW
Martin Wilson, reporting
John Militello, planned sale of RCKTW shares
John Militello, reporting
John Militello, planned sale of RCKTW shares
John Militello, reporting
Martin Wilson, planned sale of RCKTW shares
Martin Wilson, reporting
Nasdaq Stock Market LLC, filed by
Martin Wilson, insider filing for RCKTW
Martin Wilson, reporting
Gaurav Shah, planned sale of RCKTW shares
Gaurav Shah, reporting
Gaurav Shah, insider filing for RCKTW
Gaurav Shah, reporting
Sarbani Chaudhuri, insider filing for RCKTW
Sarbani Chaudhuri, reporting
Martin Wilson, planned sale of RCKTW shares
Martin Wilson, reporting
Christopher James Stevens, planned sale of RCKTW shares
Christopher James Stevens, reporting
Christopher James Stevens, insider filing for RCKTW
Christopher James Stevens, reporting
Ownership stake disclosure by VANGUARD PORTFOLIO MANAGEMENT LLC
VANGUARD PORTFOLIO MANAGEMENT LLC, filed by
Joseph Manhede, new insider at RCKTW
Joseph Manhede, reporting
Fady Ibraham Malik, planned sale of RCKTW shares
Fady Ibraham Malik, reporting
Mikael Dolsten, insider filing for RCKTW
Mikael Dolsten, reporting
John Militello, insider filing for RCKTW
John Militello, reporting
Gaurav Shah, insider filing for RCKTW
Gaurav Shah, reporting
Gaurav Shah, insider filing for RCKTW
Gaurav Shah, reporting
Gaurav Shah, planned sale of RCKTW shares
Gaurav Shah, reporting
Gaurav Shah, planned sale of RCKTW shares
Gaurav Shah, reporting